Drug Development Archives - Oncology Central Oncology Central

i
i

14 Jul 2020 Hematologic
Fadraciclib: a new and improved CDK inhibitor for cancer
17 Jun 2020 News
Novel drug-screening technique could help identify effective cancer therapies in mice
3 Jun 2020 News
Immunotherapy response boosted by tumor-penetrating peptides in mice
19 May 2020 Brain and neurologic
Novel immunotherapy combination shows promise for pediatric medulloblastoma in mice
15 May 2020 Skin
Outcomes of retreatment with anti-PD-1 monotherapy after response to first course in patients with cutaneous melanoma
6 Apr 2020 Immuno-oncology
Neoadjuvant immunotherapy could improve survival in colon cancer
16 Mar 2020 Drug development
Novel platinum chemotherapy in development with promising preclinical results
28 Feb 2020 News
Combination therapy could boost efficacy for endometrial, colorectal and gastric tumors
25 Feb 2020 Lung
Leukemia drugs could be used against treatment-resistant lung cancer
17 Feb 2020 Videos
Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at USA oncology practices
10 Feb 2020 Opinion
Overcoming resistance to CAR-T therapy: an interview with Saad Kenderian
29 Jan 2020 News
Cancer patients are waiting longer for the most innovative treatments to reach the clinic